Citadel Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-33,100
| Closed | -$103K | – | 15356 |
|
|
2021
Q4 | $103K | Buy |
33,100
+8,600
| +35% | +$28.9K | ﹤0.01% | 12700 |
|
|
2021
Q3 | $88K | Sell |
24,500
-31,400
| -56% | -$118K | ﹤0.01% | 12999 |
|
|
2021
Q2 | $200K | Buy |
55,900
+43,000
| +333% | +$152K | ﹤0.01% | 12169 |
|
|
2021
Q1 | $50K | Sell |
12,900
-11,300
| -47% | -$46.7K | ﹤0.01% | 12908 |
|
|
2020
Q4 | $102K | Buy |
24,200
+10,300
| +74% | +$39.7K | ﹤0.01% | 10215 |
|
|
2020
Q3 | $52K | Buy |
+13,900
| New | +$59.2K | ﹤0.01% | 9597 |
|
|
2019
Q1 | – | Sell |
-13,100
| Closed | -$48K | – | 10394 |
|
|
2018
Q4 | $48K | Sell |
13,100
-7,300
| -36% | -$25.6K | ﹤0.01% | 8499 |
|
|
2018
Q3 | $57K | Buy |
20,400
+4,600
| +29% | +$12.9K | ﹤0.01% | 8780 |
|
|
2018
Q2 | $47K | Buy |
+15,800
| New | +$37.5K | ﹤0.01% | 8450 |
|
|
2018
Q1 | – | Sell |
-12,900
| Closed | -$38K | – | 9247 |
|
|
2017
Q4 | $38K | Buy |
12,900
+2,700
| +26% | +$7.46K | ﹤0.01% | 7713 |
|
|
2017
Q3 | $30K | Sell |
10,200
-6,800
| -40% | -$20.7K | ﹤0.01% | 7291 |
|
|
2017
Q2 | $48K | Sell |
17,000
-1,300
| -7% | -$2.74K | ﹤0.01% | 7102 |
|
|
2017
Q1 | $35K | Sell |
18,300
-2,000
| -10% | -$3.86K | ﹤0.01% | 7135 |
|
|
2016
Q4 | $36K | Buy |
20,300
+9,100
| +81% | +$18.6K | ﹤0.01% | 6946 |
|
|
2016
Q3 | $30K | Buy |
+11,200
| New | +$28.4K | ﹤0.01% | 6965 |
|
|
2016
Q1 | – | Sell |
-10,600
| Closed | -$51K | – | 9235 |
|
|
2015
Q4 | $51K | Buy |
10,600
+6,400
| +152% | +$36.3K | ﹤0.01% | 7307 |
|
|
2015
Q3 | $23K | Sell |
4,200
-10,600
| -72% | -$78.2K | ﹤0.01% | 8085 |
|
|
2015
Q2 | $118K | Buy |
14,800
+14,300
| +2,860% | +$123K | ﹤0.01% | 6931 |
|
|
2015
Q1 | $5K | Sell |
500
-3,300
| -87% | -$45.1K | ﹤0.01% | 8343 |
|
|
2014
Q4 | $46K | Sell |
3,800
-4,000
| -51% | -$60.8K | ﹤0.01% | 7264 |
|
|
2014
Q3 | $133K | Sell |
7,800
-2,900
| -27% | -$42.1K | ﹤0.01% | 6141 |
|
|
2014
Q2 | $129K | Buy |
10,700
+3,000
| +39% | +$28.4K | ﹤0.01% | 6015 |
|
|
2014
Q1 | $65K | Buy |
+7,700
| New | +$62.1K | ﹤0.01% | 6566 |
|
Other funds holding BDSI
Citadel Advisors's BDSI Position: Q1 2022 in Review
Citadel Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 84,499 shares — an estimated $262K sold.
Citadel Advisors first reported a position in BDSI in Q1 2014 and held it in 29 quarters. The position peaked at $5.85M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Citadel Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 84,499 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $262K.
- Citadel Advisors first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 29 quarters.
- Citadel Advisors's BioDelivery Sciences International, Inc. position peaked at $5.85M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.